CLINICAL_TRIALS
research
· 2026-02-05
Clinical Trial Update: Assessment of Psilocybin (TRP-8802) in Concert With Psychotherapy in Patients With Irritable Bowel Syndrome (IBS) [Phase 2]
Summary
A Phase 2 clinical trial evaluating psilocybin TRP-8802 with psychotherapy for irritable bowel syndrome is currently active but not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: TRYP Therapeutics | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: ACTIVE_NOT_RECRUITING